WaveMan
WaveMan · Company
GRDN · Guardian Pharmacy Services, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

GRDN Guardian Pharmacy Services (GRDN) Insider Trading, Ownership & Congress Trades

Wholesale & Retail · Retail-drug stores and proprietary stores · CIK 0001802255
Quote by TradingView
SEC filings
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
110
13F, latest reported quarter
Conversions, 180 days
17
Codes C/M, not in net · no price filed

Guardian Pharmacy Services insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

No insider purchases or sales are on record for Guardian Pharmacy Services, Inc. in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Pharmacy Investors, LLC
SELL
2026-03-24 SECtraded 2026-03-20
827,636
$24.6M
+7.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 28, 2025.
  • The trade is 79.9% of the 1,035,928 shares held after it.
  • 8 other insiders sold within 30 days.
  • 110 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Pharmacy Investors, LLC sold about $24.6M of GRDN on Mar 20, 2026; 8 other insiders sold within 30 days and 110 funds added in the latest 13F quarter.
Burke Fred
See Remarks
SELL
2026-03-24 SECtraded 2026-03-20
671,432
$19.9M
+7.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 28, 2025.
  • The trade is 79.9% of the 840,413 shares held after it.
  • 8 other insiders sold within 30 days.
  • 110 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Burke Fred sold about $19.9M of GRDN on Mar 20, 2026; 8 other insiders sold within 30 days and 110 funds added in the latest 13F quarter.
Morris David K
See Remarks
SELL
2026-03-24 SECtraded 2026-03-20
187,855
$5.6M
+7.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 28, 2025.
  • The trade is 73.8% of the 254,472 shares held after it.
  • 8 other insiders sold within 30 days.
  • 110 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: See Remarks Morris David K sold about $5.6M of GRDN on Mar 20, 2026; 8 other insiders sold within 30 days and 110 funds added in the latest 13F quarter.
Salentine Thomas J Jr
Director
SELL
2026-03-24 SECtraded 2026-03-20
3,570,677
$106.0M
+7.4%
Context
  • 3 earlier Form 4 trades (code P or S) here by this insider (1 buy, 2 sales), the last on May 28, 2025.
  • The trade is 79.9% of the 4,469,316 shares held after it.
  • 8 other insiders sold within 30 days.
  • 110 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Salentine Thomas J Jr sold about $106.0M of GRDN on Mar 20, 2026, the largest insider sale at the company on our record; 8 other insiders sold within 30 days and 110 funds added in the latest 13F quarter.
Bindley Capital Partners I, LLC
SELL
2026-03-24 SECtraded 2026-03-20
3,570,677
$106.0M
+7.4%
Context
  • 2 earlier Form 4 trades (code P or S) here by this insider (2 sales), the last on May 28, 2025.
  • The trade is 79.9% of the 4,469,316 shares held after it.
  • 8 other insiders sold within 30 days.
  • 110 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Insider Bindley Capital Partners I, LLC sold about $106.0M of GRDN on Mar 20, 2026, the largest insider sale at the company on our record; 8 other insiders sold within 30 days and 110 funds added in the latest 13F quarter.
36 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 31 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
no House purchase disclosed in the last 12 months
Funds
110 funds bought in last quarter
more than 52% of Wholesale & Retail
Revenue
+17.9% year over year
more than 83% of Wholesale & Retail
Margin
3.4% net margin
more than 66% of Wholesale & Retail
Buybacks
no share repurchases reported
Short interest
11.1% of the float short (float per yahoo 2026-10-26) · 3.1 days to cover · settled 2026-09-30
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch GRDN

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+39.8%12M
-4%+21%+46%+71%2025-102025-122026-022026-042026-062026-082026-10 2026-03-20 · Salentine Thomas J Jr sold $106.0M2026-03-20 · Bindley Capital Partners I, LLC sold $106.0M2026-03-20 · BINDLEY WILLIAM E sold $106.0M2026-03-20 · Pharmacy Investors, LLC sold $24.6M2026-03-20 · Ackerman John sold $24.6M2026-03-20 · Burke Fred sold $19.9M2026-03-20 · Forbes Kendall sold $10.3M2026-03-20 · Ackerman John sold $8.2M2026-03-20 · Cardinal Equity Fund, L.P. sold $8.2M2026-03-20 · Morris David K sold $5.6M2025-12-03 · COSLER STEVEN D bought $99.8K
Insider buyInsider sell
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns GRDN: institutional holders (13F)

13F holdings, latest reported quarter
FMR LLC
3,241,612 sh
$135.7M
WELLINGTON MANAGEMENT GROUP LLP
1,729,032 sh
$72.4M
BlackRock, Inc.
1,575,989 sh
$66.0M
VANGUARD CAPITAL MANAGEMENT LLC
1,379,750 sh
$57.8M
Woodline Partners LP
1,306,340 sh
$54.7M

Congress trades in GRDN

No Congress trades reported
No House member has disclosed a trade in this stock. See what Congress is buying.

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

GRDN planned insider sales (Form 144)

No planned-sale notices
No insider has filed to sell. Watch this after a run-up.

GRDN mutual fund holders (N-PORT)

Funds ranked by the share of their own portfolio in this stock (N-PORT).
Buffalo Early Stage Growth Fund
$1.7M position · as of 2026-06-30
2.2%
Ranger Micro Cap Fund
$234.0K position · as of 2026-07-31
2.0%
Lazard US Small Cap Equity Select Portfolio
$706.8K position · as of 2026-06-30
1.9%
AMG TimesSquare Small Cap Growth Fund
$1.9M position · as of 2026-06-30
1.7%
Lazard Global Small Cap Equity Portfolio
$352.9K position · as of 2026-06-30
1.7%
LISANTI SMALL CAP GROWTH FUND
$306.7K position · as of 2026-06-30
1.6%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M · % is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Burke
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$845.8K
$845.8K
$995.7K
+88%
n/a
2024
$766.1K
$766.1K
$682.7K
+27%
n/a
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 110 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
CVNAWMTAMZNSNXWRVLVAZOPSMTWLFCTDUPURBNTTSH

GRDN financials

Revenue growth
+17.9%
XBRL, annual
Net margin
3.4%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$1.5B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+4.5%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.00x
long-term debt only, 2025-12-31 (6 months older than the period end); equity 2026-06-30
Cash flow to debt
n/a
no debt to cover
Return on equity
+30.1%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+16.5%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+36.1%
operating income after a 30.6% effective tax rate, over long-term debt only, 2025-12-31 (6 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
+34.0%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Enterprise value
n/a
no share count filed
FCF yield
n/a
no share count filed
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-12
Revenue$1.4B$1.2B
Gross profit$292.7M$244.4M
Operating income$72.7M-$62.9M
Net income$49.2M-$110.0M
Operating cash flow$100.3M$58.0M
Cash$65.6M$4.7M
Long-term debt$0$0
SEC XBRL, fiscal years, as known on 2026-10-28

GRDN Stock Sonar score 5/7 axes

Find similar shapesCompare

GRDN ranks highest on financial health (99th percentile) and profitability (89th), and lowest on institutional and government (52nd), among Wholesale & Retail peers.

ProfitHealthGrowthInstitutionsRisk
Profitability
89
Inputs
  • Return on equity+30.1% · 84 pct, sector of 206
  • Return on assets+16.5% · 93 pct, sector of 257
  • Return on invested capital+36.1% · 84 pct, sector of 109
  • Return on capital employed+34.0% · 94 pct, sector of 220
Financial health
100
Inputs
  • Debt to equity0.00x · 100 pct, sector of 222
  • Cash flow to debtno debt to cover
Growth
83
Inputs
  • Revenue growth, YoY+17.9% · 83 pct, sector of 311
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Institutional and government
52
Inputs
  • Funds adding, latest quarter110 · 52 pct, sector of 234
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
72
Inputs
  • Short interest, % of float+11.1% · 24 pct, sector of 320
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 242
  • New text in Risk Factors, latest 10-K+3.1% · 93 pct, sector of 226
2 not measured: Insider conviction, US patents
  • Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies